• Je něco špatně v tomto záznamu ?

Minimum information required for a DMET experiment reporting

J. Kumuthini, M. Mbiyavanga, ER. Chimusa, J. Pathak, P. Somervuo, RH. Van Schaik, V. Dolzan, C. Mizzi, K. Kalideen, RS. Ramesar, M. Macek, GP. Patrinos, A. Squassina,

. 2016 ; 17 (14) : 1533-45. [pub] 20160822

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031488

AIM: To provide pharmacogenomics reporting guidelines, the information and tools required for reporting to public omic databases. MATERIAL & METHODS: For effective DMET data interpretation, sharing, interoperability, reproducibility and reporting, we propose the Minimum Information required for a DMET Experiment (MIDE) reporting. RESULTS: MIDE provides reporting guidelines and describes the information required for reporting, data storage and data sharing in the form of XML. CONCLUSION: The MIDE guidelines will benefit the scientific community with pharmacogenomics experiments, including reporting pharmacogenomics data from other technology platforms, with the tools that will ease and automate the generation of such reports using the standardized MIDE XML schema, facilitating the sharing, dissemination, reanalysis of datasets through accessible and transparent pharmacogenomics data reporting.

Centre for Proteomic and Genomic Research Cape Town South Africa

Centre for Proteomic and Genomic Research Cape Town South Africa Computational Biology Group Institute for Infectious Diseases and Molecular Medicine University of Cape Town South Africa

Department of Bioinformatics Faculty of Medicine and Health Sciences Erasmus University Medical Center Rotterdam The Netherlands Department of Pharmacy School of Health Sciences University of Patras Patras Greece

Department of Bioinformatics Faculty of Medicine and Health Sciences Erasmus University Medical Center Rotterdam The Netherlands Department of Physiology and Biochemistry Faculty of Medicine and Surgery University of Malta Malta

Department of Biology and Medical Genetics Charles University Prague and 2nd Faculty of Medicine Prague Czechia

Department of Clinical Chemistry Erasmus University Medical Center Rotterdam Room Na 415 Wytemaweg 80 3015CN Rotterdam The Netherlands

Division of Biomedical Statistics and Informatics Department of Health Sciences Research Mayo Clinic 200 1st Street SW Rochester MN 55905 USA

Institute of Biotechnology University of Helsinki Helsinki Finland

Laboratory of Pharmacogenomics Section of Neuroscience and Clinical Pharmacology Department of Biomedical Sciences University of Cagliari sp 8 Sestu Monserrato Km 0 700 09042 Cagliari Italy

Pharmacogenetics Laboratory Institute of Biochemistry Faculty of Medicine University of Ljubljana Vrazov trg 2 SI 1000 Ljubljana Slovenia

UCT SA MRC Human Genetics Research Unit Division of Human Genetics Institute for Infectious Diseases and Molecular Medicine Division of Human Genetics University of Cape Town South Africa

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031488
003      
CZ-PrNML
005      
20171102110714.0
007      
ta
008      
171025s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.2217/pgs-2016-0015 $2 doi
035    __
$a (PubMed)27548815
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kumuthini, Judit $u Centre for Proteomic & Genomic Research, Cape Town, South Africa.
245    10
$a Minimum information required for a DMET experiment reporting / $c J. Kumuthini, M. Mbiyavanga, ER. Chimusa, J. Pathak, P. Somervuo, RH. Van Schaik, V. Dolzan, C. Mizzi, K. Kalideen, RS. Ramesar, M. Macek, GP. Patrinos, A. Squassina,
520    9_
$a AIM: To provide pharmacogenomics reporting guidelines, the information and tools required for reporting to public omic databases. MATERIAL & METHODS: For effective DMET data interpretation, sharing, interoperability, reproducibility and reporting, we propose the Minimum Information required for a DMET Experiment (MIDE) reporting. RESULTS: MIDE provides reporting guidelines and describes the information required for reporting, data storage and data sharing in the form of XML. CONCLUSION: The MIDE guidelines will benefit the scientific community with pharmacogenomics experiments, including reporting pharmacogenomics data from other technology platforms, with the tools that will ease and automate the generation of such reports using the standardized MIDE XML schema, facilitating the sharing, dissemination, reanalysis of datasets through accessible and transparent pharmacogenomics data reporting.
650    _2
$a interpretace statistických dat $7 D003627
650    _2
$a lidé $7 D006801
650    _2
$a šíření informací $7 D033181
650    12
$a farmakogenetika $7 D010597
650    12
$a výzkumný projekt $7 D012107
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mbiyavanga, Mamana $u Centre for Proteomic & Genomic Research, Cape Town, South Africa.
700    1_
$a Chimusa, Emile R $u Centre for Proteomic & Genomic Research, Cape Town, South Africa. Computational Biology Group, Institute for Infectious Diseases & Molecular Medicine, University of Cape Town, South Africa.
700    1_
$a Pathak, Jyotishman $u Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
700    1_
$a Somervuo, Panu $u Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
700    1_
$a Van Schaik, Ron Hn $u Department of Clinical Chemistry, Erasmus University Medical Center Rotterdam, Room Na-415, Wytemaweg 80, 3015CN Rotterdam, The Netherlands.
700    1_
$a Dolzan, Vita $u Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1000 Ljubljana, Slovenia.
700    1_
$a Mizzi, Clint $u Department of Bioinformatics, Faculty of Medicine & Health Sciences, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Physiology & Biochemistry, Faculty of Medicine and Surgery, University of Malta, Malta.
700    1_
$a Kalideen, Kusha $u UCT/SA MRC Human Genetics Research Unit, Division of Human Genetics, Institute for Infectious Diseases & Molecular Medicine, Division of Human Genetics, University of Cape Town, South Africa.
700    1_
$a Ramesar, Raj S $u UCT/SA MRC Human Genetics Research Unit, Division of Human Genetics, Institute for Infectious Diseases & Molecular Medicine, Division of Human Genetics, University of Cape Town, South Africa.
700    1_
$a Macek, Milan $u Department of Biology & Medical Genetics, Charles University Prague & 2nd Faculty of Medicine, Prague, Czechia.
700    1_
$a Patrinos, George P $u Department of Bioinformatics, Faculty of Medicine & Health Sciences, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.
700    1_
$a Squassina, Alessio $u Laboratory of Pharmacogenomics, Section of Neuroscience & Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, sp 8 Sestu-Monserrato, Km 0.700, 09042 Cagliari, Italy.
773    0_
$w MED00008477 $t Pharmacogenomics $x 1744-8042 $g Roč. 17, č. 14 (2016), s. 1533-45
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27548815 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171102110807 $b ABA008
999    __
$a ok $b bmc $g 1255081 $s 992515
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 17 $c 14 $d 1533-45 $e 20160822 $i 1744-8042 $m Pharmacogenomics $n Pharmacogenomics $x MED00008477
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace